I am looking for…
European eCTD dossiers, ready-to-market Rx/OTC products, reliable CMO manufacturing capacity, regional distribution partners or bolt-on acquisitions.
Submit a sourcing mandateStrategic business development, licensing and cross-border partnerships, from mandate to signed term sheet.
Headquartered in Copenhagen, Generix partners with pharmaceutical manufacturers, Marketing Authorisation Holders (MAHs), dossier owners and commercial executives across international markets.
Successful partnerships take more than introductions. They depend on alignment across dossier readiness, regulatory pathways, supply reliability and deal economics. We pre-qualify counterparties and structure viable opportunities, so leadership teams can focus their capital and BD time where execution is most likely.
About Generix
Qualified Rx, OTC and value-added products, plus audited EU and international CMO/CDMO supply partners.
Learn more 02In-licensing, out-licensing and Marketing Authorisation transfers that accelerate portfolio growth.
Learn more 03Targeted partner origination, feasibility assessment and structured deal progression.
Learn more 04Vetted importers, wholesalers and partners across Europe, MENA and selected emerging markets.
Learn more 05Discreet, mandate-driven introductions between strategic buyers, sellers and corporate counterparties.
Learn moreWe define the commercial, technical and regulatory parameters: target territories, dossier formats (eCTD/CTD) and deal structure.
Using our industry intelligence, we identify pre-vetted manufacturers, MAHs and counterparties that match your profile.
We manage CDA-protected introductions and feasibility discussions directly with the decision-makers.
We keep momentum through term sheet alignment, due diligence coordination and long-term partnership structuring.
European eCTD dossiers, ready-to-market Rx/OTC products, reliable CMO manufacturing capacity, regional distribution partners or bolt-on acquisitions.
Submit a sourcing mandateProprietary dossiers, out-licensing rights, commercialised MAs, specialised manufacturing capabilities or an asset for strategic divestment.
Present your assetOur current portfolio of generic medicines, EU dossiers and oncology injectables is shared with qualified partners on request.

Whether you are expanding your therapeutic portfolio, monetising existing dossiers or entering new international territories, Generix brings the reach and discipline to execute.